Alterations and Mechanism of Gut Microbiota in Graves’ Disease and Hashimoto’s Thyroiditis
Polish Journal of Microbiology · 09.06.2022 · 71 (2) · 173-189
DOI: 10.33073/pjm-2022-016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Polish Journal of Microbiology, online erschienen am 09.06.2022. Verfasst von Hong Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine, Xiang'an Hospital of Xiamen University, Xiamen, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Graves Disease, Hashimoto Disease. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
To explore the role of gut microbiota in Graves’ disease (GD) and Hashimoto’s thyroiditis (HT). Seventy fecal samples were collected, including 27 patients with GD, 27 with HT, and 16 samples from healthy volunteers. Chemiluminescence was used to detect thyroid function and autoantibodies (FT3, FT4, TSH, TRAb, TGAb, and TPOAb); thyroid ultrasound and 16S sequencing were used to analyze the bacteria in fecal samples; KEGG (Kyoto Encyclopedia of Genes and Genomes) and COG (Clusters of Orthologous Groups) were used to analyze the functional prediction and pathogenesis. The overall structure of gut microbiota in the GD and HT groups was significantly different from the healthy control group. Proteobacteria and Actinobacteria contents were the highest in the HT group. Compared to the control group, the GD and HT groups had a higher abundance of Erysipelotrichia, Cyanobacteria, and Ruminococcus _2 and lower levels of Bacillaceae and Megamonas . Further analysis of KEGG found that the “ABC transporter” metabolic pathway was highly correlated with the occurrence of GD and HT. COG analysis showed that the GD and HT groups were enriched in carbohydrate transport and metabolism compared to the healthy control group but not in amino acid transport and metabolism. Our data suggested that Bacillus , Blautia , and Ornithinimicrobium could be used as potential markers to distinguish GD and HT from the healthy population and that “ABC transporter” metabolic pathway may be involved in the pathogenesis of GD and HT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrine, Xiang'an Hospital of Xiamen University, Xiamen, China.
- Department of Medical Laboratory Technology, Xiamen Medical College, Xiamen, China.
- Department of Endocrine, Daqing Oilfield Hospital, Daqing, China.
- Basic Medical College, Xinjiang Medical University, Wulumuqi, China.
- Department of Nephrology, Zhuhai People's Hospital, Zhuhai, China.
- Department of Rheumatology and Immunology, Xiang'an Hospital of Xiamen University, Xiamen, China.
Zitieren
APA
Zhao, H., Yuan, L., Zhu, D., Sun, B., Du, J., & Wang, J. (2022). Alterations and Mechanism of Gut Microbiota in Graves’ Disease and Hashimoto’s Thyroiditis. Polish Journal of Microbiology, 71(2), 173-189. https://doi.org/10.33073/pjm-2022-016
Vancouver
Zhao H, Yuan L, Zhu D, Sun B, Du J, Wang J. Alterations and Mechanism of Gut Microbiota in Graves’ Disease and Hashimoto’s Thyroiditis. Polish Journal of Microbiology. 2022;71(2):173-189. doi:10.33073/pjm-2022-016
BibTeX
@article{Zhao2022,
author = {Zhao, Hong and Yuan, Lijie and Zhu, Dongli and Sun, Banghao and Du, Juan and Wang, Jingyuan},
title = {Alterations and Mechanism of Gut Microbiota in Graves’ Disease and Hashimoto’s Thyroiditis},
journal = {Polish Journal of Microbiology},
year = {2022},
volume = {71},
number = {2},
pages = {173--189},
doi = {10.33073/pjm-2022-016}
}
EUVIMED